ITMI912024A1 - Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac. - Google Patents

Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.

Info

Publication number
ITMI912024A1
ITMI912024A1 IT002024A ITMI912024A ITMI912024A1 IT MI912024 A1 ITMI912024 A1 IT MI912024A1 IT 002024 A IT002024 A IT 002024A IT MI912024 A ITMI912024 A IT MI912024A IT MI912024 A1 ITMI912024 A1 IT MI912024A1
Authority
IT
Italy
Prior art keywords
therapeutic compositions
intranasal administration
administration including
ketorolac
including ketorolac
Prior art date
Application number
IT002024A
Other languages
English (en)
Inventor
Ettore Bilato
Giuseppe Bottoni
Soldato Piero Del
Original Assignee
Recordati Ind Chimica E Farma Ceutica S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11360400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI912024(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of ITMI912024A0 publication Critical patent/ITMI912024A0/it
Priority to ITMI912024A priority Critical patent/IT1250691B/it
Application filed by Recordati Ind Chimica E Farma Ceutica S P A filed Critical Recordati Ind Chimica E Farma Ceutica S P A
Priority to EP92112394A priority patent/EP0524587B1/en
Priority to DK92112394.9T priority patent/DK0524587T3/da
Priority to ES92112394T priority patent/ES2082288T3/es
Priority to DE69206345T priority patent/DE69206345T2/de
Priority to AT92112394T priority patent/ATE130758T1/de
Priority to JP19357492A priority patent/JP3586735B2/ja
Publication of ITMI912024A1 publication Critical patent/ITMI912024A1/it
Priority to US08/383,707 priority patent/US6333044B1/en
Publication of IT1250691B publication Critical patent/IT1250691B/it
Application granted granted Critical
Priority to GR960400413T priority patent/GR3019012T3/el
Priority to US09/903,665 priority patent/US7267827B2/en
Priority to US10/792,457 priority patent/US7476689B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ITMI912024A 1991-07-22 1991-07-22 Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac. IT1250691B (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ITMI912024A IT1250691B (it) 1991-07-22 1991-07-22 Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
EP92112394A EP0524587B1 (en) 1991-07-22 1992-07-20 Therapeutic compositions for intranasal administration which include ketorolac TM
DK92112394.9T DK0524587T3 (da) 1991-07-22 1992-07-20 Terapeutiske sammensætninger til intranasal indgivelse indeholdende Ketorolac R
ES92112394T ES2082288T3 (es) 1991-07-22 1992-07-20 Composiciones terapeuticas para administracion intranasal de ketorolaco.
DE69206345T DE69206345T2 (de) 1991-07-22 1992-07-20 Arzneimittel zur intranasalen Verabreichung, die Ketorolac R enthalten.
AT92112394T ATE130758T1 (de) 1991-07-22 1992-07-20 Arzneimittel zur intranasalen verabreichung, die ketorolac r enthalten.
JP19357492A JP3586735B2 (ja) 1991-07-22 1992-07-21 ５−ベンゾイル−２，３−ジヒドロ−１ｈ−ピロリジン−１−カルボン酸を含有する鼻内投与用治療組成物
US08/383,707 US6333044B1 (en) 1991-07-22 1995-02-01 Therapeutic compositions for intranasal administration which include KETOROLAC®
GR960400413T GR3019012T3 (en) 1991-07-22 1996-02-15 Therapeutic compositions for intranasal administration which include ketorolac TM.
US09/903,665 US7267827B2 (en) 1991-07-22 2001-07-13 Therapeutic compositions for intranasal administration which include KETOROLAC
US10/792,457 US7476689B2 (en) 1991-07-22 2004-03-02 Therapeutic compositions for intranasal administration which include KETOROLAC

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912024A IT1250691B (it) 1991-07-22 1991-07-22 Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.

Publications (3)

Publication Number Publication Date
ITMI912024A0 ITMI912024A0 (it) 1991-07-22
ITMI912024A1 true ITMI912024A1 (it) 1993-01-23
IT1250691B IT1250691B (it) 1995-04-21

Family

ID=11360400

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI912024A IT1250691B (it) 1991-07-22 1991-07-22 Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.

Country Status (9)

Country Link
US (3) US6333044B1 (it)
EP (1) EP0524587B1 (it)
JP (1) JP3586735B2 (it)
AT (1) ATE130758T1 (it)
DE (1) DE69206345T2 (it)
DK (1) DK0524587T3 (it)
ES (1) ES2082288T3 (it)
GR (1) GR3019012T3 (it)
IT (1) IT1250691B (it)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883115A (en) * 1992-11-09 1999-03-16 Pharmetrix Division Technical Chemicals & Products, Inc. Transdermal delivery of the eutomer of a chiral drug
ES2095183B1 (es) * 1994-06-29 1997-12-16 S A L V A T Lab Sa Composiciones acusosas gelificantes para la administracion intranasal de farmacos.
AU714797B2 (en) * 1996-06-14 2000-01-13 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes, methods of making and use thereof
US6596777B1 (en) 1997-05-29 2003-07-22 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes
JP4754067B2 (ja) * 1997-12-02 2011-08-24 アルキメデス ディヴェロプメント リミテッド 鼻孔投与用組成物
FR2781156B1 (fr) * 1998-07-20 2001-06-29 Lafon Labor Composition pharmaceutique destinee notamment a la prevention et au traitement des radiomucites et des chimiomucites
AUPP494798A0 (en) * 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
EP1031346B1 (en) 1999-01-27 2002-05-02 Idea Ag Noninvasive vaccination through the skin
ES2173679T3 (es) * 1999-01-27 2002-10-16 Idea Ag Inmunizacion/transporte transnasal con vehiculos altamente adaptables.
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US7977376B2 (en) * 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
GB0210264D0 (en) * 2002-05-03 2002-06-12 Arakis Ltd The treatment of pain and migraine headache
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20021684A1 (it) * 2002-07-29 2004-01-29 Therapicon Srl Composizione farmaceutica di peptide nasale
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
EP1572217B1 (en) * 2002-12-12 2008-08-20 Nycomed GmbH Combination medicament of r,r-formoterol and ciclesonide
JPWO2004113332A1 (ja) * 2003-06-19 2006-07-27 小野薬品工業株式会社 経鼻製剤
ATE444732T1 (de) 2003-08-07 2009-10-15 Allergan Inc Zusammensetzungen zur abgabe von therapeutika in die augen und verfahren zu ihrer herstellung und verwendung
PT1670482E (pt) * 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
US20050175679A1 (en) * 2004-02-10 2005-08-11 Michael Moshman Controlled release formulations
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
WO2005102354A1 (en) * 2004-04-20 2005-11-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
NZ555247A (en) * 2004-12-23 2010-06-25 Roxro Pharma Inc Therapeutic compositions for intranasal administration of ketorolac
US7838532B2 (en) * 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
JP2009504767A (ja) * 2005-08-17 2009-02-05 フレミング・アンド・カンパニー・ファーマシューティカルズ ビタミンｂ１２鼻用スプレーおよび使用方法
WO2009040595A1 (en) * 2007-09-28 2009-04-02 Wockhardt Research Centre Multi-dose pharmaceutical composition of analgesic for nasal administration
EP3272379A1 (en) 2008-02-07 2018-01-24 The University of Washington Circumferential aerosol device
US7842714B2 (en) * 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
JP2011524366A (ja) * 2008-06-13 2011-09-01 ロクスロ・ファーマ・インコーポレイテッド 鼻内投与のためのケトロラクの薬学的処方物
BRPI0920026B1 (pt) 2008-10-07 2023-11-07 Horizon Orphan Llc Composição farmacêutica e respectivos usos
DK2346509T3 (da) 2008-10-07 2020-08-03 Horizon Orphan Llc Inhalation af levofloxacin til at reducere lungeinflammation
US8277781B2 (en) * 2009-03-13 2012-10-02 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
US8551454B2 (en) 2009-03-13 2013-10-08 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
IN2012DN02477A (it) 2009-09-04 2015-08-21 Mpex Pharmaceuticals Inc
WO2012024595A2 (en) * 2010-08-20 2012-02-23 University Of Washington Circumferential aerosol device for delivering drugs to olfactory epithelium and brain
RU2612506C2 (ru) 2011-03-03 2017-03-09 Импел Ньюрофарма Инк. Устройство для назальной доставки лекарственных средств
WO2012127497A1 (en) 2011-03-04 2012-09-27 Cadila Healthcare Limited Stable pharmaceutical compositions of ketorolac or salts thereof
CA2835208C (en) 2011-05-09 2019-08-20 Impel Neuropharma, Inc. Nozzles for nasal drug delivery
CA2909954C (en) 2013-04-28 2021-03-23 Impel Neuropharma, Inc. Medical unit dose container
EP3129013A1 (en) * 2014-04-10 2017-02-15 Crowley, Patrick Delivery of non-steroidal antiinflammatory agents to the brain via the nasal tract to treat neurological disorders
US11266799B2 (en) 2015-09-10 2022-03-08 Impel Neuropharma, Inc. In-line nasal delivery device
EP3345592A1 (en) * 2017-01-09 2018-07-11 Michael Laird Hurrey Enhanced stability ketorolac formulations and methods and devices for use with same
US11053037B2 (en) * 2017-10-06 2021-07-06 Hikma Pharmaceuticals Usa Inc. System and method for purging oxygen from medical vials
WO2019104205A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with dip tube
CA3081680A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with inlet interface
AU2019205318B2 (en) 2018-01-05 2022-02-03 Impel Pharmaceuticals Inc. Intranasal delivery of dihydroergotamine by precision olfactory device
WO2019136308A1 (en) 2018-01-05 2019-07-11 Impel Neuropharma, Inc. Intranasal delivery of olanzapine by precision olfactory device
US11517548B2 (en) 2018-07-19 2022-12-06 Impel Pharmaceuticals Inc. Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
KR20210109007A (ko) 2019-01-03 2021-09-03 임펠 뉴로파마 인코포레이티드 비강 약물 전달 장치
CN114025816A (zh) 2019-05-17 2022-02-08 英倍尔药业股份有限公司 一次性鼻腔给送装置

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089569A (en) * 1976-02-19 1978-05-16 Sycor, Inc. Resilient mount for the driving shaft of an impact matrix printer and the like
US4089969A (en) 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
JPS539788A (en) * 1976-07-14 1978-01-28 Syntex Inc 55aloyll1*22dihydroo3hh pyroro *1*22a* pyroll11 carboxylic acid derivative
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
US4478822A (en) 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
IT1169873B (it) * 1983-10-21 1987-06-03 Prodotti Formenti Srl Composizione farmaceutica ad attivita' sistemica anticolinesterasica, agonista-colinergica ed antimuscarinica
US5049386A (en) * 1985-01-07 1991-09-17 Syntex (U.S.A.) Inc. N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5122127A (en) * 1985-05-01 1992-06-16 University Of Utah Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
DE3601923A1 (de) * 1986-01-23 1987-07-30 Behringwerke Ag Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
US4919939A (en) * 1986-04-29 1990-04-24 Pharmetrix Corporation Periodontal disease treatment system
NZ222907A (en) * 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
US4778810A (en) 1987-01-08 1988-10-18 Nastech Pharmaceutical Co., Inc. Nasal delivery of caffeine
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
US4943587A (en) * 1988-05-19 1990-07-24 Warner-Lambert Company Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues and their use for cyclooxygenase and 5-lipoxygenase inhibition
US4973596A (en) * 1988-05-20 1990-11-27 Barr Laboratories, Inc. Method of administering a narcotic analgesic and dosage forms therefor
US4885287A (en) * 1988-08-09 1989-12-05 University Of Kentucky Research Foundation Novel method of administering aspirin and dosage forms containing same
GB8900267D0 (en) 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
JPH07112984B2 (ja) * 1989-04-28 1995-12-06 久光製薬株式会社 泡状エアゾール製剤
US5091182A (en) * 1990-07-23 1992-02-25 Syntex (U.S.A.) Inc. Dispensing units for ketorolac topical gel formlations
US5143731A (en) * 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5855907A (en) * 1997-03-24 1999-01-05 Peyman; Gholam A. Method of treatment of migraine
US6090368A (en) * 1998-03-03 2000-07-18 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine

Also Published As

Publication number Publication date
ES2082288T3 (es) 1996-03-16
DE69206345D1 (de) 1996-01-11
EP0524587A1 (en) 1993-01-27
US6333044B1 (en) 2001-12-25
ATE130758T1 (de) 1995-12-15
US7476689B2 (en) 2009-01-13
US20040171666A1 (en) 2004-09-02
DK0524587T3 (da) 1996-04-09
DE69206345T2 (de) 1996-04-25
JPH05194215A (ja) 1993-08-03
US20020077346A1 (en) 2002-06-20
EP0524587B1 (en) 1995-11-29
JP3586735B2 (ja) 2004-11-10
GR3019012T3 (en) 1996-05-31
ITMI912024A0 (it) 1991-07-22
US7267827B2 (en) 2007-09-11
IT1250691B (it) 1995-04-21

Similar Documents

Publication Publication Date Title
ITMI912024A1 (it) Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
DK383987A (da) Ny galeniske formuleringer med programmeret afgivelse indeholdende antiphlogistika
NO991056D0 (no) Rene enantiomere basiske aryl-cykloalkyl-hydroksykarboksylsyreestere, fremgangsmÕte for deres fremstilling og anvendelse derav i medikamenter
DK0503440T3 (da) Sumatriptanholdige lægemidler
DK0510404T3 (da) Gastroresistente farmaceutiske formuleringer til oral administration indeholdende galdesyresalte
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
DE69329400D1 (de) L-Dopa Ester enthaltende Zusammensetzung
DK0652000T3 (da) Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et lægemiddel til inhibering af angiogenese og angiogene sygdomme
NO20003313D0 (no) Terapeutiske midler
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
AP9901474A0 (en) Pharmaceutical composition for treating viral diseases.
LU90791I2 (fr) Potentialisateur d'effets antineoplasique et agent antineoplasique
EP0535250A4 (en) Novel compounds and use thereof as medicine
MY133438A (en) Morpholinobenzamide salts
DE69522827D1 (de) Fibrinogen receptor antagonisten mit substituierten b-aminosäurenestern und diese enthaltende pharmazeutische präparate
FI923662A0 (fi) Terapeutiska medel.
MX9302929A (es) Derivados de tetrahidro y perhidroisoquinolina y medios terapeuticos que los contienen.
SE9002067D0 (sv) The pharmacological use of certain cystine derivatives

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960730